These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33350184)

  • 41. Poor Rhythm Outcome of Catheter Ablation for Early-Onset Atrial Fibrillation in Women　- Mechanistic Insight.
    Yu HT; Yang PS; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Circ J; 2018 Aug; 82(9):2259-2268. PubMed ID: 29887578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of SCN10A Polymorphisms with the Recurrence of Atrial Fibrillation after Catheter Ablation in a Chinese Han Population.
    Wu H; Xu J; Chen S; Zhou G; Qi B; Wei Y; Hu E; Tang D; Chen G; Li H; Zhao L; Shi Y; Liu S
    Sci Rep; 2017 Mar; 7():44003. PubMed ID: 28281580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome.
    Richter B; Gwechenberger M; Socas A; Marx M; Gössinger HD
    Am J Cardiol; 2008 Mar; 101(6):843-7. PubMed ID: 18328850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Five-year follow-up outcome after catheter ablation of persistent atrial fibrillation using a sequential biatrial linear defragmentation approach: What does atrial fibrillation termination during the procedure imply?
    Miyazaki S; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Hirao K; Iesaka Y
    Heart Rhythm; 2017 Jan; 14(1):34-40. PubMed ID: 27590435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Takagi K; Fujino T; Kimura S; Hikita H; Tomita M; Hirao K; Isobe M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):267-73. PubMed ID: 24610740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of a 4q25 genetic variant in atrial flutter and on the risk of atrial fibrillation after cavotricuspid isthmus ablation.
    Roberts JD; Hsu JC; Aouizerat BE; Pullinger CR; Malloy MJ; Kane JP; Olgin JE; Marcus GM
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):271-277. PubMed ID: 24237655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort.
    Chalazan B; Mol D; Sridhar A; Alzahrani Z; Darbar SD; Ornelas-Loredo A; Farooqui A; Argos M; Daviglus ML; Konda S; Rehman J; Darbar D
    PLoS One; 2018; 13(4):e0194480. PubMed ID: 29624624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
    Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up.
    Naruse Y; Tada H; Sekiguchi Y; Machino T; Ozawa M; Yamasaki H; Igarashi M; Kuroki K; Itoh Y; Murakoshi N; Yamaguchi I; Aonuma K
    Heart Rhythm; 2011 Mar; 8(3):335-41. PubMed ID: 21056121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic Susceptibility to Atrial Fibrillation Is Associated With Atrial Electrical Remodeling and Adverse Post-Ablation Outcome.
    Wong GR; Nalliah CJ; Lee G; Voskoboinik A; Prabhu S; Parameswaran R; Sugumar H; Anderson RD; Ling LH; McLellan A; Johnson R; Sanders P; Kistler PM; Fatkin D; Kalman JM
    JACC Clin Electrophysiol; 2020 Nov; 6(12):1509-1521. PubMed ID: 33213811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect: a comparison with transcatheter closure alone.
    Nakagawa K; Akagi T; Nagase S; Takaya Y; Kijima Y; Toh N; Watanabe A; Nishii N; Nakamura K; Morita H; Kusano K; Ito H
    Europace; 2019 Nov; 21(11):1663-1669. PubMed ID: 31410454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation.
    Wongcharoen W; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Chong E; Chao TF; Tuan TC; Chang YT; Lin CY; Liao JN; Lin YC; Chen YY; Chen SA
    Heart Rhythm; 2015 Sep; 12(9):1956-62. PubMed ID: 26049050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience.
    Bertaglia E; Tondo C; De Simone A; Zoppo F; Mantica M; Turco P; Iuliano A; Forleo G; La Rocca V; Stabile G
    Europace; 2010 Feb; 12(2):181-7. PubMed ID: 19887458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient.
    Yang PS; Kim TH; Uhm JS; Park S; Joung B; Lee MH; Pak HN
    Europace; 2016 Nov; 18(11):1711-1718. PubMed ID: 26838688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Common Variants in the TBX5 Gene Associated with Atrial Fibrillation in a Chinese Han Population.
    Zhang R; Tian X; Gao L; Li H; Yin X; Dong Y; Yang Y; Xia Y
    PLoS One; 2016; 11(8):e0160467. PubMed ID: 27479212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population.
    Cao H; Zhou Q; Lan R; Røe OD; Chen X; Chen Y; Wang D
    PLoS One; 2014; 9(11):e112912. PubMed ID: 25402477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive electrocardiography monitoring for very early recurrence predicts long-term outcome in patients after atrial fibrillation ablation.
    Yang DY; Cheng ZW; Liu YT; Gao P; Chen TB; Deng H; Cheng KA; Fan JB; Fang Q
    Ann Noninvasive Electrocardiol; 2020 Nov; 25(6):e12785. PubMed ID: 32588512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation.
    Kiliszek M; Kozluk E; Franaszczyk M; Lodzinski P; Piatkowska A; Ploski R; Opolski G
    Arch Med Sci; 2016 Feb; 12(1):38-44. PubMed ID: 26925117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.